It couldn’t have been worse than Panadol went out of stock at this point. . Pakistan is experiencing floods right now, making Panadol very popular.
A company that makes panadol, a widely used OTC drug, has stopped manufacturing it in Pakistan.
Panadol’s manufacturer GSK claims production was generally unprofitable and has asked for authorization to increase the cost of the medication.
The pharmaceutical Manufacturing Association of Pakistan (PMA) says that:
The medicine had sent a rundown to the wellbeing service suggesting an increment of Rs. 1 for every tablet, be that as it may, the government bureau dismissed the synopsis.
Since then, the company that makes 450 million tablets a month has stopped making them.
Punjab is experiencing an emergency now that there isn’t enough Panadol available. Natural ingredients were hard to find in the global business world, and the medicine was cheap, so the medicine had already started disappearing from local markets.
Government officials denied the company’s request to raise the price of the product. Panadol shortages have been going on for a while now.
According to monetary specialists, The drug company was supposed to pass its administrative cost control checks, and the cost increase was supposed to be approved in February.
However, the new government disapproved of the increased value, and the statement of disapproval movement made matters difficult.
Panadol can be used to treat fevers, migraines, and inoculation-related pain.
A large number of flood-affected areas use this medication to treat intestinal sickness, dengue fever, respiratory diseases, and typhoid.
Recently, because of the increase in dengue cases in metropolitan areas, there has been a decline in interest.
